WHO ICTRP trial
Effect of intravenous N-acetylcysteine on prevention of atrial fibrillation…
IRCT2015040921669N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015040921669N1 |
|---|---|
| Public title | Effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after Coronary Artery Bypass Graft surgery(CABG) . |
| Scientific title | Effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after Coronary Artery Bypass Graft surgery(CABG) |
| Primary sponsor | Mazandaran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Atrial Fibrillation. Atrial fibrillation and flutter;Atrial fibrillation and flutter |
| Interventions | Intervention 1: Double blind clinical trial. Intervention 2: In the intervention group, 50 mg of N-acetylcysteine will be administered intravenously during the procedure, 24 and 48 hours after surgery, within 30 minutes. Intervention 3: In… |
| Registration date | Sep 12, 2016 |
| Target size | 150 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: